Dr. Sawsan Youssef, M.Sc. Ph.D.

CSO, Immunologist, PhD in immunology, Adaptive Immune System, ImmunoOncology , autoimmunity and inflammation, Bioengineering, innovator, Scientists, Educator.

[Immunity @ImmunityCP]

Check out or April issue with a special collection of Reviews & Perspectives on Type 2 Immunity from @RMedzhitov, @LizKopp1 &co, Henrique Veiga-Fernandes & @neuroimmune_rok, Richard Locksley & @Molofsky_lab, Erika Pearce, Edward Pearce, & Agnieszka Kabat https://t.co/onwszHRNiz

[Andrew Pannu @andrewpannu]

RNA therapies market map

124 companies are segmented by approach and highest stage of development

Some takeaways:

[Maarten Larmuseau @MHDLarmuseau]

Today we finally published the genomic analyses of hair locks from world-famous music composer Ludwig van #Beethoven. The #genome offers clues to his health and family history! 🧬💇‍♂️ @CurrentBiology https://t.co/aI9J4cNoL0 (credits: Beethoven-Haus Bonn; T. Begg)
🧵 1/11

[Nature Biomedical Engineering @natBME]

A peritumourally implanted macroporous scaffold releasing small molecules and antibodies to suppress regulatory T cells and to attract and stimulate effector T cells enhanced endogenous antitumoural responses in mice bearing aggressive tumours.

https://t.co/qot3AGlB4r

[Science Immunology @SciImmunology]

The March issue of Science #Immunology is out now!

The cover study shares findings that could help revamp human IgG1 Fc-engineering strategies to enhance future generations of anti-PD-L1 #cancer #immunotherapy drugs: https://t.co/v9mFAeSX4h

[Nature Cancer @NatureCancer]

💫DON’T MISS this Review on “Advances in antibody-based therapy in oncology” @NatureCancer by #SaschaZinn #RodrigoVazquezLombardi #CarstenZimmermann #PujaSapra #LutzJermutus and #DanielChrist.

Read it here 👇
https://t.co/WqY1FByRmD
https://t.co/zrRwnSiKr0

[Journal of Clinical Investigation @jclinicalinvest]

#Review: Next-generation antigen-presenting cell immune therapeutics for gliomas: https://t.co/lIqTpHX1Ev

by @CatyLeechang & @maciejlesniakmd @NUFeinbergMed in JCI's latest #ReviewSeries: Immune Environment in Glioblastoma: https://t.co/uW68prMHGw

[TIME @TIME]

For the last two decades, Lionel Messi and Cristiano Ronaldo have dominated the game of soccer. Here’s how they compare after the World Cup
https://t.co/8cLM68TIpO

[FIFA World Cup @FIFAWorldCup]

🇦🇷👑

[Barack Obama @BarackObama]

Congrats to Argentina and to the GOAT, Lionel Messi, for an amazing World Cup victory.

[Eric Topol @EricTopol]

Just published @CellCellPress
"Alarming antibody evasion properties of rising #SARSCoV2 BQ and XBB subvariants"
These are the current US variants to reckon with.
Were it not for the immunity wall that's been built, we'd be having a much rougher go at it
https://t.co/VqxKpU5ZKu

[Pfizer Inc. @pfizer]

BREAKING: With our partner @BioNTech_Group, we received EUA from the @US_FDA for our Omicron-adapted #COVID19 vaccine in children 6mos-4yrs. Doses to be shipped immediately upon recommendation by CDC. Learn more: https://t.co/RtTBrUjD0o

[Nature Reviews Drug Discovery @NatRevDrugDisc]

Top product forecasts for 2023 https://t.co/XUmnGptBkf - a new analysis of the expected top-selling products next year @ByAmyBrown @EvaluatePharma, places the immune checkpoint inhibitor Keytruda at the top

[Nature Reviews Drug Discovery @NatRevDrugDisc]

For readers interested in the history of immune checkpoint inhibitors for cancer therapy, here's a recent perspective https://t.co/Qa6X0UaCMy

[Nature Biotechnology @NatureBiotech]

Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases https://t.co/LczwcsgV3S

[DNA&RNA Universe 𝕏 @DNA_RNA_Uni]

RNA [screams internally]

[Journal of Experimental Medicine @JExpMed]

Boieri, @CaImmunoprevent et al. demonstrate that CD4+ T helper cells directly block #breastcancer development by forcing the cancer cells to terminally differentiate. https://t.co/ykzBgS4ZsR

From our #Cancer #Immunotherapy collection: https://t.co/vZLDRiauiJ

#SITC22

[Nature Reviews Drug Discovery @NatRevDrugDisc]

Those readers attending the Resistance to Checkpoint Blockade Immunotherapy session at #SITC22 this morning, might find this article by Lieping Chen of interest https://t.co/DdKBjChBli

[Dr. Sawsan Youssef, M.Sc. Ph.D. @DRSY2000]

@MayoLior Distributed Bio /CRL

[Human Immunology News @humanimmunenews]

📢 There's a new #review in @sigtrans_sttt!

It describes the efforts to manipulate the immune system against #cancer, and different targets and cell types that can be exploited to promote the antitumor immune response.

📌 Read it here: https://t.co/uYcOheoh3o